Pierce David A
SEC CIK 1529751 · EDGAR
BoughtSold
Most active insiders at DHC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bilotto Christopher J. | Pres, CEO, Dir | $97.8K | — |
| 2 | Felder Alan L. | Dir | — | — |
| 3 | Neher Dawn K. | Dir | — | — |
| 4 | Hollis Phyllis M. | Dir | — | — |
| 5 | Brown Matthew C. | CFO, Treas | — | — |
| 6 | JONES LISA HARRIS | Dir | — | — |
| 7 | SOMERS JEFFREY P. | Dir | — | — |
| 8 | PORTNOY ADAM D. | Dir | — | — |
Pierce David A made no open-market trades at DHC in the last 12 months.
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-06 | 2023-06-05 | DHC | DIVERSIFIED HEALTHCARE TRUST | Pierce David A | Dir | A - Grant | — | +20.0K | 40.0K | +100% | — | |
| 2022-06-03 | 2022-06-02 | DHC | DIVERSIFIED HEALTHCARE TRUST | Pierce David A | Dir | A - Grant | — | +20.0K | 20.0K | New | — | |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | F - Tax | $44.17 | -718 | 1,726 | -29% | -$31.7K |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | M - OptEx | $0.00 | +2,444 | 2,444 | New | $0 |
| D | 2022-03-02 | 2022-03-01 | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | S - Sale+OE | $43.94 | -1,726 | 0 | -100% | -$75.8K |
| DM | 2022-02-24 | 2022-02-22+ | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | S - Sale | $42.90 | -3,645 | 0 | -100% | -$156.4K |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | F - Tax | $42.55 | -732 | 3,645 | -17% | -$31.1K |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | M - OptEx | $0.00 | +2,493 | 4,377 | +132% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | F - Tax | $42.71 | -1,763 | 4,238 | -29% | -$75.3K |
| D | 2022-02-22 | 2022-02-18 | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | S - Sale+OE | $42.88 | -2,354 | 1,884 | -56% | -$100.9K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | M - OptEx | $0.00 | +6,001 | 5,022 | New | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | F - Tax | $44.01 | -813 | 1,956 | -29% | -$35.8K |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | M - OptEx | $0.00 | +2,769 | 2,769 | New | $0 |
| D | 2022-02-17 | 2022-02-16 | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | S - Sale+OE | $43.81 | -1,956 | 0 | -100% | -$85.7K |
| 2022-01-05 | 2022-01-04 | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | S - Sale | $43.54 | -6,161 | 0 | -100% | -$268.2K | |
| D | 2022-01-03 | 2022-01-01 | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | M - OptEx | $0.00 | +8,982 | 8,982 | New | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | F - Tax | $42.48 | -2,821 | 6,161 | -31% | -$119.8K |
| D | 2021-12-21 | 2021-12-20 | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | S - Sale+OE | $39.90 | -50.0K | 0 | -100% | -$1.99M |
| DM | 2021-12-21 | 2021-12-20 | BSX | Boston Scientific | Pierce David A | EVP Pres MedSurg | M - OptEx | $7.27 | +47.9K | 50.0K | +2,330% | +$348.7K |
Purchase Sale Sale after option exercise All abbreviations